| Recruiting | Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer Advanced Pancreatic Ductal Adenocarcinoma, Cancer Anorexia-Cachexia Syndrome | N/A | 2026-01-20 |
| Recruiting | Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis Solid Tumours, Olanzapine, Nausea and Vomiting | — | 2026-01-18 |
| Recruiting | The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2- Breast Cancer, HER2/CEP17 Ratio | — | 2026-01-10 |
| Recruiting | Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregio Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer | Phase 3 | 2026-01-05 |
| Recruiting | SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | Phase 2 | 2025-11-30 |
| Not Yet Recruiting | Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer: A Prospective Clinical Tr Pancreatic Cancer | Phase 2 | 2025-10-01 |
| Not Yet Recruiting | Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes Breast Cancer | N/A | 2025-09-30 |
| Not Yet Recruiting | Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Sa Pancreatic Cancer, Locally Advanced Pancreatic Cancer | Phase 1 | 2025-09-10 |
| Not Yet Recruiting | Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer Breast Cancer | Phase 4 | 2025-08-01 |
| Not Yet Recruiting | Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-cente Rectal Cancer, Rectal Cancer Patients | Phase 3 | 2025-07-30 |
| Recruiting | BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligomet Hepatocellular Carcinoma, Portal Vein Tumor Thrombus, Oligometastases | Phase 2 | 2025-07-25 |
| Recruiting | Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogre OligoProgressive Metastatic Disease, Hepatocellular Carcinoma (HCC), Radiotherapy | Phase 3 | 2025-07-21 |
| Recruiting | SFRT and SCART in Radiotherapy for Bone Metastases With Soft Tissue Bone Metastases in Subjects With Advanced Cancer | N/A | 2025-06-01 |
| Recruiting | Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cance Rectal Malignant Neoplasms | Phase 2 | 2025-05-30 |
| Recruiting | Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients | Phase 1 / Phase 2 | 2025-05-25 |
| Recruiting | Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma Soft Tissue Sarcoma (STS) | N/A | 2025-05-20 |
| Recruiting | Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy Breast Cancer | Phase 2 | 2025-05-01 |
| Recruiting | Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Ce Cervical Cancer, Neoplasm Recurrence, Local, Oligometastatic | Phase 2 | 2025-02-28 |
| Recruiting | Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonesc Pancreatic Cancer | Phase 1 / Phase 2 | 2025-02-08 |
| Recruiting | Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rha Rhabdomyosarcoma, Recurrent, Refractory | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squ Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | 2024-12-15 |
| Not Yet Recruiting | A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Solid Tumor Cancer, Chemotherapy Induced Neutropenia, G-CSF | N/A | 2024-10-10 |
| Recruiting | Early Screening Cohort Study of Multiple Gastrointestinal Tumors Early Detection of Cancer | — | 2024-09-10 |
| Recruiting | Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence Colorectal Neoplasms Malignant | Phase 2 | 2024-06-24 |
| Recruiting | Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | Phase 2 | 2024-06-13 |
| Completed | WASPE Sleep Adjustment for Children Aged 0-4 Years Undergoing Radiation Therapy Pediatric Cancer | N/A | 2024-06-01 |
| Recruiting | A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer Esophageal Cancer, Dysphagia, Esophageal, Epigallocatechin Gallate | Phase 2 | 2024-04-22 |
| Recruiting | Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Colorectal Cancer, Immunotherapy, Radiotherapy | Phase 2 | 2024-04-01 |
| Terminated | First-line Treatment for Unresectable Locally Advanced Distal Cholangiocarcinoma Combining Radiotherapy and HA Intrahepatic Cholangiocarcinoma | Phase 2 | 2024-04-01 |
| Recruiting | Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer Hepatocellular Carcinoma, Radiotherapy | — | 2024-03-01 |
| Recruiting | Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Adva Rectal Cancer | — | 2023-12-01 |
| Recruiting | Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer Pancreas Cancer | Phase 2 | 2023-08-18 |
| Completed | Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia Pneumonia, Interstitial, Cancer Patients | Phase 2 | 2023-06-05 |
| Recruiting | A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell L The First Affiliated Hospital of Nanchang University | Phase 2 | 2023-06-01 |
| Unknown | Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients Interstitial Pneumonia, Neoplasms Malignant | Phase 1 / Phase 2 | 2023-01-05 |
| Recruiting | Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC IMMUNOTHERAPY, Neoadjuvant Therapy, Resectable Lung Non-Small Cell Carcinoma | Phase 2 | 2022-12-02 |
| Completed | CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer Small Cell Lung Cancer | — | 2022-11-28 |
| Unknown | Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell C Advanced Esophageal Squamous Cell Cancer | Phase 2 | 2022-04-20 |
| Unknown | A Phase I Study of IBI325 in Patients With Advanced Solid Tumor Solid Tumor | Phase 1 | 2022-03-23 |
| Unknown | A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 | 2022-03-01 |
| Unknown | Patient Report Outcome and Oncological Safety -Oncoplastic and Conventional BCS Cohort Patient Reported Outcome, Oncological Safety, Breast-conserving Surgery | — | 2021-10-01 |
| Completed | Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophage Esophageal Obstruction | Phase 1 | 2021-08-20 |
| Recruiting | Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Limited Stage Small Cell Lung Cancer | Phase 3 | 2021-04-26 |
| Unknown | A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Hepatocellular Carcinoma | Phase 2 | 2021-03-17 |
| Unknown | A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectab Unresectable Stage III NSCLC | Phase 2 | 2021-01-21 |
| Unknown | Pyrotinib Combined With Trastuzumab And Chemotherapy in HER2-positive MBC HER2-positive Breast Cancer, Metastatic Breast Cancer | — | 2021-01-01 |
| Unknown | Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis Breast Cancer, HER2-positive Breast Cancer | Phase 2 | 2021-01-01 |
| Terminated | A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-sm Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-11-12 |
| Unknown | A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients Non Small Cell Lung Cancer | Phase 2 | 2020-11-04 |
| Unknown | Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer Breast Cancer, Sentinel Lymph Node | N/A | 2020-11-01 |
| Unknown | A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell L Non Small Cell Lung Cancer | Phase 2 | 2020-10-08 |
| Active Not Recruiting | SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC Extensive-stage Small Cell Lung Cancer | Phase 2 | 2020-10-01 |
| Unknown | A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-li Non-Small-Cell Lung Cancer | Phase 2 | 2020-09-01 |
| Unknown | A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma Glioblastoma | Phase 2 | 2020-09-01 |
| Unknown | Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC) Triple Negative Breast Cancer | Phase 2 | 2020-05-20 |
| Unknown | Capecitabine Plus Pyrotinib Versus Capecitabine Plus Trastuzumab and Pertuzumab in the First-line Treatment of Metastatic Breast Cancer | Phase 2 | 2020-01-01 |
| Unknown | Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2019-10-25 |
| Unknown | Metabolomics Explores Biomarkers for Metastatic Breast Cancer Breast Cancer | — | 2019-10-01 |
| Unknown | Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib Recurrent Glioblastoma | Phase 1 / Phase 2 | 2019-06-25 |
| Unknown | Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC Carcinoma, Non-Small Cell Lung | Phase 3 | 2018-12-12 |
| Unknown | Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients Carcinoma, Non-Small-Cell Lung | Phase 2 | 2018-11-01 |
| Unknown | Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors Radiation Toxicity, Advanced Cancer, Radiosensitivity | — | 2018-10-08 |
| Unknown | Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy HER2-positive Breast Cancer | Phase 2 | 2018-10-01 |
| Unknown | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NS Non-Small-Cell Lung Cancer | Phase 2 | 2018-07-09 |
| Unknown | Internal Mammary Sentinel Lymph Node Biopsy With Modified Injection Technique Breast Cancer | N/A | 2018-07-01 |
| Unknown | Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients Carcinoma, Non-Small-Cell Lung | N/A | 2018-01-15 |
| Unknown | The Multi-center Validation Study of Internal Mammary Lymph Biopsy With Modified Injection Technique in Breast Breast Neoplasm | — | 2017-08-01 |
| Unknown | Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer Breast Cancer | N/A | 2017-06-01 |
| Unknown | Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Recruitment | — | 2017-01-01 |
| Unknown | Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases Brain Metastases | N/A | 2016-12-02 |
| Unknown | Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGF EGFR-TKI Resistant Mutation, Nonsmall Cell Lung Cancer, AZD9291 | Phase 3 | 2016-12-01 |
| Unknown | Shandong Cancer Hospital Affiliated to Shandong University Early-stage Breast Cancer, Breast Conserving Surgery | Phase 3 | 2016-11-01 |
| Unknown | Temperature and Injury in Radiotherapy Radiation Skin Injury Breast Neoplasm Female, Radiation Toxicity | — | 2016-10-02 |
| Completed | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignanci Malignancies, Stomach Cancer, Non-small Cell Lung Cancer | Phase 4 | 2016-09-30 |
| Unknown | Prophylactic Treatment of Hepatic Dysplastic Nodules in HBsAg Positive Patients Dysplastic Nodule of Liver, Chronic Hepatitis B | N/A | 2016-09-01 |
| Terminated | A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC Esophageal Neoplasms | Phase 4 | 2016-08-01 |
| Terminated | A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC Esophageal Neoplasms | Phase 4 | 2016-07-05 |
| Completed | A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC Esophageal Neoplasms | Phase 4 | 2016-02-25 |
| Unknown | Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2015-09-01 |
| Unknown | Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer Lung Neoplasms | Phase 3 | 2015-05-01 |
| Unknown | Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Rad Lung Neoplasms, Esophagitis, Prevention & Control | Phase 2 | 2015-04-01 |
| Unknown | A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell C Prosthesis Survival | Phase 3 | 2015-03-01 |
| Unknown | Study of Epigallocatechin-3-gallate (EGCG) for Skin Prevention in Patients With Breast Cancer Receiving Adjuva Breast Neoplasms, Dermatitis, Prevention & Control | Phase 2 | 2014-12-01 |
| Unknown | Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 4 | 2014-08-01 |
| Unknown | Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Canc Non Small Cell Lung Cancer | Phase 2 | 2014-07-01 |
| Completed | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Pos Breast Cancer | Phase 3 | 2014-02-01 |
| Unknown | A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma Glioblastoma | N/A | 2013-08-01 |
| Withdrawn | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node Breast Cancer | Phase 3 | 2013-01-01 |
| Unknown | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma PHENYTOIN/SORAFENIB [VA Drug Interaction], Carcinoma, Hepatocellular | Phase 2 | 2012-07-01 |
| Unknown | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate He PHENYTOIN/SORAFENIB [VA Drug Interaction], Liver Neoplasms, Carcinoma, Hepatocellular | Phase 2 | 2012-05-01 |
| Completed | Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Neg Breast Cancer | Phase 2 | 2012-01-01 |
| Unknown | Study of Topically Applied Green Tea Extract for Radio Dermatitis and Radiation Mucositis Epigallocatechin Gallate, Radio Dermatitis, Radiation Mucositis | Phase 1 / Phase 2 | 2011-09-01 |
| Unknown | Intraoperative Molecular Diagnosis of Sentinel Lymph Node In Breast Cancer Patients Sentinel Lymph Node Biopsy | N/A | 2010-02-01 |
| Unknown | IMRT/Pemetrexed/Cisplatin in Esophageal Cancer Esophageal Cancer | — | 2009-10-01 |
| Completed | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma Esophageal Cancer | Phase 2 | 2009-01-01 |
| Unknown | Study of Breast Cancer Shrinkage Modes After Neoadjuvant Chemotherapy With Whole-mount Serial Sections and Thr Breast Cancer | Phase 3 | 2008-08-01 |
| Available | Oral Green Tea Extract for Small Cell Lung Cancer Small Cell Lung Carcinoma | — | — |